This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 08 Dec 2015  |  Asia Pacific  |  Market Research

    A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

    Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth

    The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

    $6,000.00
  2. 11 Nov 2015  |  Asia Pacific  |  Market Research

    Asia-Pacific Point-of-Care Testing Market

    Trends, Challenges, and Best Practices for Stakeholders

    Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...

    $4,950.00
  3. 26 Oct 2015  |  Asia Pacific  |  Market Research

    Asia-Pacific Regulations Driving Innovation in Healthcare

    Innovative Public-Private Initiatives Attracting Investment in Research & Development

    The following article is an abstract of some recent whitepapers developed by Frost & Sullivan on the evolving regulatory policies impacting healthcare in Asia-Pacific (APAC). Government initiatives and incentives in the APAC have resulted in increasing investment in research and development (R&D) in healthcare, while free trade economics across the...

    $1,500.00
  4. 30 Sep 2015  |  Europe  |  Market Research

    Profiling the Top Mergers and Acquisition Within Medical Devices Space

    Changing Healthcare Dynamics Driving the M&A

    The landscape of healthcare is rapidly changing worldwide as governments are reducing healthcare spending through means such as reimbursement cuts. The medical devices market bears the direct brunt of these measures. To overcome this, medical device companies are involved in active mergers and acquisitions (M&A). The study analyses the key factors ...

    $1,500.00
  5. 30 Sep 2015  |  Europe  |  Technology Research

    Advanced mechanisms in drug delivery

    Impact and assessment of modern mechanisms in drug delivery systems

    The research service aims to give a global outlook of the companion diagnostic market landscape, with a specific focus on Western European countries. The segments related to oncology discussed in this study include breast cancer, lung cancer, colorectal cancer and other cancers, and non-oncology related infectious disease, CNS, and cardiovascular. ...

    $4,950.00
  6. 29 Sep 2015  |  Europe  |  Market Research

    Analysis of the European Digital and Computed Radiography Markets

    Workflow Integration Provides Potential for Growth

    This research service presents an analysis of the digital and computed radiography markets in Europe. It also provides an in-depth analysis of the market and discusses market characteristics such as size, revenue forecasts, drivers, restraints, market penetration and market attractiveness for both the digital radiography (DR) and the computed rad...

    $4,950.00
  7. 28 Sep 2015  |  Asia Pacific  |  Market Research

    End-User Perspectives on the SEA RIS/ PACS Market

    Next-generation Imaging IT Needs Will Focus on Interoperability

    Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...

    $4,950.00
  8. 03 Sep 2015  |  Asia Pacific  |  Market Research

    Impact of Policies Shaping ASEAN Healthcare—Outlook till 2020

    Policies Raising Standards and Lowering Barriers Across ASEAN

    The research service provides an analysis of the policies impacting the healthcare market in the Association of Southeast Asian Nations (ASEAN). It includes the current trends, market size, revenue forecast, and market drivers and restraints. Healthcare market participants and key opinion leaders were interviewed to obtain their perception about tr...

    $2,450.00
  9. 02 Sep 2015  |  Asia Pacific  |  Market Research

    Analysis of the Global Human Albumin Market and Product Pipeline

    Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities

    The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

    $4,950.00
  10. 24 Aug 2015  |  Europe  |  Market Research

    Assessing Ultrasounds Market Potential within Emerging Clinical Points of Care

    Beyond Traditional Users, New Clinical Departments Grow Their Potential as Customer Segments

    The growth of the ultrasound market is driven by the emerging clinical segment, as the established clinical segment has reached a saturation stage in select regions of NA and Western Europe. Growing awareness about the harmful effects of radiation exposure from other imaging modalities and delivery of sonogram services at the site of patients who a...

    $6,950.00